Abstract. Our previous immunofluorescence studies support the conclusion that the temporal appearance and subcellular distribution of TS28 (a marker of transverse (T) tubules and caveolae in adult skeletal muscle [Jorgensen, A. O., W. Arnold, A. C.-Y. Shen, S. Yuan, M. Gover, and K. P. . J. Cell Biol. 110:1173-1185), correspond very closely to those of T-tubules forming de novo in developing rabbit skeletal muscle (Yuan, S., W. Arnold, and A. O. . J. Ceil Biol. 110:1187-1198.
Abstract. Our previous immunofluorescence studies support the conclusion that the temporal appearance and subcellular distribution of TS28 (a marker of transverse (T) tubules and caveolae in adult skeletal muscle [Jorgensen, To extend our morphological studies of the biogenesis of T-tubules and triads, the temporal appearance and subcellular distribution of the o~t-subunit of the 1,4-dihydropyridine receptor (a marker of the T-tubules and caveolae) was compared to (a) that of TS28; and (b) that of the ryanodine receptor (a marker of the junctional sarcoplasmic reticulum) in rabbit skeletal muscle cells developing in situ (day 19 of gestation to 10 d newborn) by double immunofluorescence labeling.
The results presented show that the temporal appearance and relative subcellular distribution of the ct~-subunit of the 1,4-dihydropyridine receptor (otI-DHPR) are distinct from those of TS28 at the onset of the biogenesis of T-tubules. Thus, in a particular developing myotube the al-DHPR appeared before TS28 (secondary myotubes; day 19-24 of gestation). Furthermore, the otI-DHPR was distributed in discrete foci at the outer zone of the cytosol, while TS28 was confined to foci and rod-like structures at the cell periphery. As development proceeded (primary myotubes; day 24 of gestation) ,050% of the foci were positively labeled for both TS28 and the o~-DHPR, while ,020 and 30% of the foci were uniquely labeled for TS28 and the otl-DHPR, respectively. The foci labeled for both TS28 and the t~1-DHPR and the foci uniquely labeled for TS28 were generally confined to the cell periphery, while the foci uniquely labeled for the aI-DHPR were mostly confined to the outer zone of the cytosol. 1-2 d after birth, TS28 was distributed in a chickenwirelike network throughout the cytosol, while the ctm-DHPR was confined to cytosolic foci. In contrast, the temporal appearance and subcellular distribution of the o~m-DHPR and the ryanodine receptor were very similar, if not identical, throughout all the stages of the de novo biogenesis of T-tubules and triads examined.
Assuming that the subcellular distribution of TS28 represents the distribution of forming T-tubules the results presented are consistent with the following plausible scheme for the biogenesis of T-tubules and triads. Before the onset of T-tubule formation, otl-DHPR-containing cytosolic vesicles form a complex with a ryanodine receptor-containing membrane system (c~rDHPR: ryanodine receptor-complex). This complex is distributed at the outer zone of the cytosol. After the onset of formation of TS28-containing T-tubules, the a~-DHPR ryanodine receptor-complex becomes incorporated into discrete regions of the forming T-tubules at the cell periphery. Assuming that otrDHPR is complexed with the ryanodine receptorcontaining membrane system, incorporation of the otrDHPR into T-tubules also results in the formation of a junctional complex between T-tubules and the sarcoplasmic reticulum.
XCITATION-CONTRACTION coupling in adult skeletal
muscle depends on appropriate communication across the narrow gap between transverse (T) tubules and turn results in contraction. Although the message transmitted from the T-tubules to the junctional SR is still unknown it is generally accepted that the 1,4-dihydropyridine receptor (DHPR) (31) and the ryanodine receptor (6) are essential links in the excitation-contraction coupling. Biochemical (7) and immunoelectron microscopical studies (16) have demonstrated that the DHPR is densely distributed in the T-tubular membrane. The immunoeleetron microscopical studies also showed that the DHPR is present in subsarcolemmal vesicles possibly corresponding to caveolae (16) . On the basis of physiological (31) and molecular biological (38, 39) studies it has been proposed that the DHPR functions as a voltage sensor in the excitation-contraction coupling process. Characterization of the highly purified DHPR (4, 5, 10) has shown that it is composed of at least five polypeptide components including the ot~ (155-200 kD), the a2 (150 kD, reduced), the/~ (52 kD), the 3, (32 kD), and the ~ (23-29 kD) subunits. The ott-DHPR is the DHP binding component of the DHPR.
Immunoelectron microscopical localization of a component of the junctional SR biochemically characterized as the foot protein demonstrated this protein to be localized in the region of the junctional complex between T-tubules and junctional SR in skeletal muscle (18) . The rya odine receptor purified from the junctional SR (12, 13, 25, 37) functions upon reconstitution as the Ca2+-release channel of the SR (12, 25, 37) , and its structure (1, 25, 33, 43) corresponds to that of individual foot structures observed in freeze-fracture images of junctional SR (1) . Furthermore, the position of every other foot structure corresponds precisely to that of large diamond-shaped clusters of integral membrane particles in the closely apposed junctional T-tubule membrane (1). Assuming that these clusters correspond to DHPRs (26) , studies by Block et al. (1) suggested that the DHPR receptor/voltage sensor in the T-tubular membrane may complex with and, thus, activate the ryanodine receptor/Ca2+-release channel of the SR directly.
Despite the functional significance of the T-tubules and the junctional complex between the T-tubules and the junctional SR for excitation-contraction coupling in skeletal muscle, very little is known about the assembly of these structures. Ukrastructural studies have shown that de novo formation of the junctional complex occurs in developing rabbit skeletal muscle between fetal day 22 and 10 d after birth, and is preceded by the onset of the formation of T-tubules which begins at fetal days 17-19 (21) .
An ultrastructural study of the formation of T-tubules and SR in developing rat skeletal muscle in situ reported that forming T-tubules first appear as short tubular invaginations of the sarcolemma (19) . At the same time, eaveolae were frequently encountered at the cell periphery and sometimes observed to be arranged in clusters and short beaded tubular structures. At the onset of their formation T-tubules were mostly present in the subsarcolemmal region and oriented parallel to the longitudinal axis of the myofibers. As development proceeds the T-tubules branch, and extend further towards the interior regions of the myofibers, and their transverse orientation becomes more prominent (19, 34) . Before the onset of T-tubular formation SR forms transient junctional complexes with the sarcolemma (19) . As T-tubule formarion occurs the SR also forms focal junctional complexes with the forming T-tubules. These internal junctional complexes are at first located at the peripheral regions of the cytosol, and only later as the T-tubules extend further toward the central regions of the myofibers are junctional complexes between T-tubules and SR also observed in these regions. Only much later does the transverse orientation of the junctional complexes become prominent and junctional SR continuous along the entire length of the now transversely oriented T-tubules (34) . As the formation of interior junetional complexes becomes more extensive the junctional complexes between SR and sarcolemma decrease dramatically (19) .
To begin to understand the molecular aspects of the biogenesis of T-tubules we have recently used immunofluorescence labeling techniques to demonstrate that the temporal appearance and subcellular distribution of TS28 (45) (a 28-kD protein marker of T-tubules and caveolae in adult skeletal muscle distinct from the DHPR [17] ), correspond very closely to those of T-tubules forming de novo in developing rabbit skeletal muscle (21) . These results suggested that TS28 is an excellent marker of T-tubules from the onset of their formation in developing skeletal muscle and support the "add-on" model for the biogenesis of T-tubules first proposed by Schiaffino et al. (35) . In accordance with this model we proposed that to initiate the formation of a particular T-tubule a TS28-containing membrane vesicle fuses with the sarcolemma forming a TS28-containing caveolae. However, TS28 in the lipid bilayer of the caveolae is somehow prevented from ditfusing into the lateral regions of the sarcolemma. Subsequently, additional TS28-contalning vesicles fuse first with the TS28-containing caveola, forming short tubular invaginations in the subsarcolemmal region. Repeated fusions of TS28-containing transfer vesicles with the short TS28-containing tubular structures result in the formarion of further extended T-tubules (45) .
To further elucidate the sequence of events leading to the de novo biogenesis of functional T-tubules, double immunofluorescence labeling of rabbit skeletal muscle developing in situ was used to compare the temporal appearance and subcellular distribution of the c~-DHPR to those of TS28 in developing rabbit skeletal muscle during the de novo formarion of T-tubules and the junctional complex between T-tubules and junctional SR called triads (day 19 of gestation to 10 d after birth). To begin to understand how the junctional complex between the T-tubules and the junctional SR assembles, the same approach was used to compare the temporal appearance and subcellular distribution of TS28 and the ot1-DHPR to those of the ryanodine receptor, a marker of the junctional region of the SR.
The results of these studies are consistent with the idea that before the onset of T-tubule formation, aI-DHPRs form complexes with ryanodine receptors which accumulate in the outer zone of the cytosol. After the onset of formation of TS28-containing T-tubules, the ot~-DHPR ryanodine receptor complexes become incorporated into forming T-tubules, thus, possibly simultaneously incorporating the DHPR into discrete regions of the T-tubular membrane and forming a junctional complex between T-tubules and the SR.
Materials and Methods

Preparation of 7Issue Extract, Membrane Fractions, and Purification of Proteins from Rabbit Skeletal Muscle
Skeletal muscle extracts represent the supernatant obtained by extracting
The Journal of Cell Biology, Volume ! 12, 1991quick-frozen tissue with an SDS-containing buffer as outlined below. Muscle tissue was quickly dissected, frozen in liquid N2, and powdered with a precooled mortar and pestle. The muscle powder was extracted for 5 rain at room temperature with buffer A (10% SDS, 10 mM EDTA, 0.1 M Tris, 50 mM DTT, and 0.1 mM PMSF, pH 8.0) at a ratio of 100 mg/ml (net weight/vol). The extracts were centrifuged for 15 rain at 12,800 g (Eppendoff centrifuge 5412; Brinkmann Instruments Co., Westbury, NY) and the supernatant was used immediately for SDS-PAGE. The DHPR was purified as described by Campbell and Kahl (3) . The ryanodine receptor was purified as described by Imagawa et al. (12) . Protein concentrations were determined by the method of Lowry et al. (27) as modified by Peterson (29) using BSA as a standard.
Preparations and Characterization of Monoclonal and Polyclonal Antibodies
TS28. IXEll2 to TS28 was prepared and characterized as previously described (17) .
ct~-DHPR. Polyclonal antibodies to purified DHPR were raised in guinea pigs by a series of intraperitoneal injections as described by Tung (41) . The presence and specificity of antibodies to the cq-DHPR were determined by immunoblotting of SDS-PAGE-separated skeletal muscle extract, purified DHPR, and ryanodine receptor. Affinity-purified antibodies to the cq-DHPR from rabbit skeletal muscle were prepared from guinea pig ascites according to the methods of Fowler and Bennet (8) using a DHPR-nitrocellulose paper complex (100 gg DHPR/square inch nitrocellulose paper) as the affinity column.
Ryanodine Receptor. Polyclonal antibodies to immunoaflinity-purified ryanodine receptor from rabbit skeletal muscle (12) were produced in sheep as previously described (23) . Briefly, antiserum was raised in a sheep by a series of intramuscular injections with 0.5 nag of purified ryanodine receptor. The presence and specificity of antibodies to the rabbit skeletal ryanodine receptor was determined by immunoblotting of SDS-PAGE-separated, purified ryanodine receptor, DHPR, and skeletal muscle extracts.
Affinity-purified antibodies to the rabbit skeletal ryanodine receptor were prepared from sheep antiserum according to the procedure of Fowler and Bennetl (8) using a purified ryanodine receptor-nitrocellulose paper complex (100/~g ryanodine receptor/square inch nitrocellulose paper) as the affinity column. lmmunoblotting SDS-PAGE was performed by the method of Laemmli (24) using either a 7.5 % continuous polyacrylamide separating gel or a discontinuous separating gel where the top and bottom half of the separating polyacrylamide gel was 3.0 and 7.5%, respectively. Transelectrophoresis of SDS-PAGE separated proteins onto nitrocellulose and subsequent immunoblotting was performed according to the methods of Towbin et al. (40) with minor modification as outlined below.
Nitrocellulose blots were blocked in 5 % nonfat dry milk in TBS (20 mM TRIS, 500 mM NaCI, pH 7.4) (14) . The antibody incubation medium included 2.5% nonfat dry milk in TTBS (TBS containing 0.05% Tween 20) . For immunoblotting of the DHPR, the blots were incubated for 1 h with guinea pig antibodies to the ,*I-DHPR (1:1,000 dilution). The blots were then washed to remove unbound antibody, incubated with affinity-purified goat anti-guinea pig IgG conjugated to alkaline phosphatase (1:3,000 dilution; Biorad Laboratories, Ltd., Richmond, CA) in 2.5% nonfat dry milk in TTBS. The blots were rinsed twice with TTBS for 5 rain each and TBS for 10 rain. Color development was completed using 5-Bromo-4-chloro-3-indolyl phosphate-toluidine salt (BCIP)/p-nitro blue tetrazolium chloride (NBT) substrate reagents (BCIP/NBT; Biorad Laboratories Ltd.). All procedures were performed at room temperature with gentle agitation. The reaction was terminated by thoroughly rinsing the blots with water and allowing them to air dry. Immunoblotting with sheep antibodies to the ryanodine receptor was carried out as described above except that a triple-layered procedure was used. Thus, the incubation with sheep antibodies to the ryanodine receptor (1/500 dilution) was followed first by an incubation with affinity-purified goat anti-sheep IgG conjugated to biotin (1:1,000 dilution; Biorad Laboratories Ltd.) and then by an incubation with avidin-conjugated alkaline phosphatase (1:1,000 dilution; Biorad Laboratories Ltd.).
Dissection, b~xation, and Cryosectioning
Hind limb muscle tissues were dissected from rabbits at different stages of development ranging from day 19 of gestation to 2 d after birth. Bundles of myofibers from 10-d and adult rabbit gracilis muscle were dissected and tied to tooth picks at 100-120% of rest length, fixed in 2% paraformaldehyde, and infused with 0.6 M sucrose as previously described (15) . Small blocks of fixed and unfixed muscle tissues were cryofixed in isopentane, precooled in liquid N2. Cryostat sections (6-8 gin) were cut, fixed in 70% ethanol at 0°C for 5 rain, air dried, and stored in a desiccator at -20°C until use.
lndirect Immunofluorescence Labeling
Single lmmunofluorescence Labeling. Immunofluorescence labeling of 6-8-#m cryosections of fixed and unfixed muscle tissues was carried out as previously described (15) . Briefly, the sections were first labeled with one of the following antibodies: (a) afffinity-purified guinea pig antibodies to the cq-DHPR (10 #g/ml); (b) mAb IXEll2 to TS28 (1.74 #g/ml); and (c) affinity-purified sheep antibodies to the ryanodine receptor (10 #g/ml). The corresponding secondary antibodies were (a) F(ab')2 fragments of rabbit anti-guinea pig IgG conjugated to FITC (1:40 dilution; Organon Teknika Co., West Chester, PA); (b) F(alY)2 fragments of affinity-purified rabbit anti-mouse IgG eonjngated to rhodamine (1:80 dilution; Jackson Immunoresearch Laboratories Inc., West Grove, PA); and (c) F(ab')2 fragments of affinity-purified rabbit anti-sheep IgG conjugated to fluorescein or rhodamine (1:40 dilution; Jackson Immunoreseareh Laboratories Inc.).
Controls. For adsorption, 10 t~g/ml of affinity-purified antibodies to the DHPR was incubated with 0 and 60 #g/ml purified DHPR as previously described (15) . Similarly, 10 v.g/ml of affinity-purified antibodies to the ryanodine receptor was incubated with 0 and 60 gg/ml purified ryanodine receptor. The molar ratio of antigen/antibody is "~2 for the adsorption of both antibodies. The supernatants obtained by centrifugation were used as the primary reagent in the single indirect immunolabeling assay.
Double lmraunofluorescence Labeling. Double immunofluorescence
labeling of 6-8-~m cryoseetions was carried out in sequential steps combining two of the three single immunofluorescence labeling procedures described above. Double-labeling procedure A was composed of singlelabeling procedure a for the cq-DHPR followed by labeling procedure b for TS28. Double labeling procedure B was composed of single labeling procedure a for the otI-DHPR followed by procedure c for the ryanodine receptor where a rhodamine-conjugated secondary antibody was used to label the ryanodine receptor. Double-labeling procedure C was composed of single-labeling procedure c for the ryanodine receptor followed by labeling procedure b for TS28. In procedure C, a fluorescein-eonjugated secondary antibody was used to label the ryanodine receptor.
Conventional fluorescence microscopy was carried out with a Zeiss photomicroscope provided with an epifluorescence attachment and a phasecontrast condenser. Confocal fluorescence microscopy was carried out with a Nikon photomicroseope provided with a Lasersharp MRC-500 confucal fluorescence imaging system, using a dual channel detection system and an (A-C, lane 2; 5 gl)/purified DHPR (C, lane 1; 0.1 gg) and purified ryanodine receptor (A and B, lane 1; 4 #g) were prepared, separated by SDS-PAGE followed by immunoblotting with sheep antiserum to the ryanodine receptor (A) and guinea pig antibodies to the DHPR (B and C) as described in Materials and Methods. SDS-PAGE of the lanes shown in A and B were performed using 3 %/7.5 % discontinuous polyaerylamide as the separating gel. (The filled circle in A and B indicate the border between the upper 3 % and the lower 7.5% polyacrylamide gel.) SDS-PAGE of the lanes in C was performed using continuous 7.5 % polyacrylamide as the separating gel.
Argon laser for illumination (Biorad Laboratories Canada Ltd., Mississauga, Canada) (44) . The distribution of FITC-conjngated secondary antibodies was visualized by illumination with a laser line at 488 nm. The distribution of rhodamine-conjugated secondary antibodies was visualized by illumination with a laser line at 515 nm. The photographs were taken from an attached photo-recording system with high linearity.
Analysis of the Relative Distribution of arDHPR and TS28 in 24-d Fetal Skeletal Muscle
Paired confocai images showing the relative spatial distribution of c~l-DHPR (see Fig. 4 , c) and TS28 (see Fig. 4 d) in primary myofibers (n = 15) present in transverse cryosections of 24-d fetal skeletal muscle double labeled for these two proteins were traced (see Fig. 4 , e and f) in two different colors (not shown) and superimposed. By superimposing the paired tracings, three distinct classes of fluorescenfly labeled foci were identified as illustrated in Fig. 4j . One class of foci were labeled for beth cq-DHPR and TS28 (see Fig. 4j, crosses) , another class of foci was uniquely labeled for cq-DHPR (see Fig. 4j , open circles), while a third class was uniquely labeled for TS28 (see Fig. 4j, open triangles) . The sum of the number of foci in each of the three classes represents the total number of labeled foci in a particular cell. Next, the total foci and the foci in each of the three classes of foci were enumerated for each of the cells analyzed. Subsequently, the percentage of labeled foci in each of the three classes was calculated for each cell. Finally, the percentage of foci in each class was averaged over the number of cells analyzed and an SD calculated.
Results
Characterization of Antibodies to the DHPR and the Ryanodine Receptor
The specificity of the sheep antiserum towards the ryanodine receptor purified from rabbit skeletal muscle triads was demonstrated by immunoblotting of SDS-PAGE-separated ryanodine receptor and tissue extract from rabbit skeletal muscle (Fig. 1 A) . The sheep antiserum bound to a single band present in the muscle extract ( Fig. 1 A, lane 2) . The electrophoretic mobility of this band corresponds to that of the ryanodine receptor purified from rabbit skeletal muscle ( Fig. 1 A, lane/) . Furthermore, the sheep antiserum to the ryanodine receptor did not bind to the o~-DHPR also present in the muscle extract ( Fig. 1 A, lane 2, arrow) as demonstrated by immunoblotting of the same extract with antibodies to the a1-DHPR (Fig. 1 B, lane 2) .
Similarly, the specificity of the ascites from guinea pigs immunized with purified DHPR towards the a~-DHPR was demonstrated by immunoblotting of SDS-PAGE-separated DHPR ( Fig. 1 C, lane/) , tissue extracts ( Fig. 1 B, lane 2 and Fig. 1 C, lane 2) , and ryanodine receptor from rabbit skeletal muscle (Fig. 1 B, lane/) . The guinea pig antibodies to the DHPR bound to a single band with an apparent Mr of 170,000 D present in the muscle extract ( Fig. 1 B , lane 2 and 1 C, lane 2). The electrophoretic mobility of the 170,000-D band in the muscle extract ( Fig. 1 C, lane 2) corresponds to that of the o~I-DHPR of the DHPR purified from rabbit skeletal muscle (Fig. 1 C, lane/) . However, the guinea pig antibodies did not bind to either the purified ryanodine receptor (Fig. 1 B, lane/) or to the ryanodine receptor present in the muscle extract ( Fig. 1 B, lane 2) , as demonstrated by immunoblotting of the same extract with sheep antibodies to the ryanodine receptor ( Fig. 1 A, lane 2) .
These results show that the guinea pig antibodies to the DHPR specifically bind to the c~-DHPR of the DHPR and that they do not cross react with the ryanodine receptor. They also show that the sheep antiserum to the ryanodine receptor is specific for the ryanodine receptor and does not cross react with the ot~-DHPR.
SubceUular Distribution of the a~-DHPR, the Ryanodine Receptor, and TS28 in Skeletal Muscle Developing In Situ
To determine the temporal appearance and subceUular distribution of the DHPR in relation to that of TS28, the subeellular distribution of the ot~-DHPR was compared to that of TS28 in skeletal muscle developing in situ by double immunofluorescence labeling (day 19 of gestation to 15 d after birth). To determine temporal appearance and the subcellular distribution of the junctional complex between the T-tubules and the junctional SR assumed to represent the forming triad, the temporal appearance and subcellular distribution of the o~rDHPR and of TS28 were also compared to that of the ryanodine receptor by double immunofluorescence labeling of cryosections from rabbit skeletal muscle developing in situ.
Fetal Day 19-24
A mixture of myofibers with large and small diameters was observed in transverse sections at this stage of development. We assume that the large and small myofibers correspond to "primary" and "secondary" myotubes, respectively, as previously described in developing rat (20) and chick (28) skeletal muscle. Since the developmental stage of primary myotubes is ahead of that of the surrounding "secondary" myotubes, a mixture of myofibers at various stages of development is present in sections from rabbit hind limbs between fetal day 19 and day 24 of gestation.
aI-DHPR versus TS2g
Examination of transverse cryosections from 19-24-d-old fetal rabbit skeletal muscle following double labeling for the ot1-DHPR (Fig. 2, a and c ) and for TS28 (Fig. 2, b and d) showed that labeling for the o~I-DHPR was present in all large primary (Fig. 2 a, arrows) and all small secondary myotubes (Fig. 2 a, single and double arrowheads), while that for TS28 was present in all primary myotubes (Fig. 2 b, arrows) and some ( Fig. 2 b, single arrowhead) but not all small secondary myotubes (Fig.  2 b, double arrowheads) . The labeling for the ol1-DHPR was distributed in discrete foci present at both the cell periphery and the interior regions of both primary (Fig. 2, a and c, arrows) and secondary myotubes (Fig. 2, a and c, single and double arrowheads) . In contrast, TS28 as previously shown (45) was mostly confined to foci and rod-like structures at the cell periphery of the corresponding primary myotubes (Fig. 2, b and d, arrows) , and some (Fig. 2, b and d, single arrowheads) but not all secondary myotubes (Fig.  2 b, double arrowheads) . However, at this stage of development foci and rod-like structures positively labeled for TS28 were also present in the outer regions of the cytosol of some primary myofibers (Fig. 2 d, arrow) . The results presented suggest that the first appearance of the o~t-DHPR in secondary myotube precedes that of TS28. Furthermore, it is particularly obvious that the distribution of a considerable proportion of foci at the cell periphery of myotubes positively labeled for the cq-DHPR (Fig. 2, a and c, single arrowheads) is distinct from that of the foci and rod-like structures at the periphery of the corresponding myotubes positively labeled for TS28 (Fig. 2, b and d, single arrowheads) . The Figure 2 . Localization of the cq-DHPR, the ryanodine receptor, and TS28 in transverse cryosecfions of unfixed 19-24-d-old fetal rabbit skeletal muscle by conventional immunofluorescence microscopy. Transverse sections were double immunolabeled with (/) affinity-purified antibodies to the cq-DHPR (a and c) and with mAb IXEll2 to TS28 (b and d) (procedure A); (2) affinity-purified antibodies to the oq-DHPR (e and g) and with affinity-purified antibodies to the ryanodine receptor (land h) (procedure B); and (3) affinity-purified antibodies to the ryanodine receptor (i and k) and with mAb IXEll2 to TS28 (j and l) (procedure C). Specific labeling for TS28 is present in all primary myotubes (b and j, arrows) and some (b, single arrowhead) but not all secondary myotubes (b and j, doub/e antnCw.ads). TS28 labeling in primary and some secondary myotubes is confined to discrete foci or rod-like structures at the cell periphery (b, d, j, and l; arrows and single arrowheads). These rod-like structures extend from the cell periphery towards the center of the cell in some myotubes (d, arrowhead and l; arrows). In contrast, specific labeling for both the cq-DHPR (a, c, e and g) and the ryanodine receptor ~ h, i, and k) is present in discrete foci in the outer zone of the cytosol in both primary and secondary myotubes (a and e, f and i; arrows, single and double arrowheads). It is noteworthy that most of the foci labeled for the c~-DHPR (e and g) are also labeled for the ryanodine receptor (fand h). Bars, 5/~m. possibility that lack of TS28 labeling of ot~-DHPR-positive foci is due to steric hindrance is highly unlikely since the same results were obtained when labeling for TS28 preceded that for o~-DHPR in the double immunofluorescence labeling experiments.
Examination of longitudinal cryosections from 19-24-dold fetal rabbit skeletal muscle following double labeling for the ~-D H P R (Fig. 3 a) and for TS28 (Fig. 3 b) confirmed the results obtained by double labeling of transverse sections (Fig. 2, a-d) . Thus, labeling for the cq-DHPR was localized to discrete foci present at both the cell periphery and the outer zone of the cytosol (Fig. 3 a) , while the labeling for TS28 was mostly confined to the cell periphery (Fig. 3 b) . These results imply that the o~t-DI-IPR and TS28 may in part colocalize at the cell periphery and that the at-DHPR is present in discrete foci in the central region of the developing myotube where TS28-containing T-tubules are not yet present.
aI-DHPR versus Ryanodine Receptor. Examination of transverse sections double labeled for the ot~-DHPR (Fig.  2, e and g ) and for the ryanodine receptor (Fig. 2 , l a n d h) showed that specific labeling for both proteins was present in discrete foci in the outer zone of the cytosol of both primary (Fig. 2, e and f, arrows) and secondary myotubes (Fig.  2, e and f, arrowheads) . Furthermore, it was observed that a majority of the foci labeled for the ¢~-DHPR in both primary (Fig. 2, e and g, arrows) and secondary myotubes (Fig.  2, e and g, arrowheads) was also labeled for the ryanodine receptor (Fig. 2 , l a n d h; arrows and arrowheads, respectively).
Examination of longitudinal cryosection from 19-24-d fetal rabbit skeletal muscle following double labeling for the cx~-DHPR (Fig. 3 c) and for the .ryanodine receptor (Fig. 3 d) confirmed the results obtained by double labeling of transverse sections (Fig. 2, e-h) . Thus, the distribution of labeling for the ~-DHPR present in discrete foci in the cytosol (Fig. 3 c) corresponded very closely to that of the ryanodine receptor (Fig. 3 d) .
Ryanodine Receptor versus TS2& Examination of transverse sections double labeled for the ryanodine receptor (Fig. 2, i and k) and for TS28 (Fig. 2, j and l) showed that positive labeling for the ryanodine receptor was present in all primary (Fig. 2, i and k, arrows) and secondary myotubes (Fig. 2, i and k, double arrowheads) , while that for TS28 was present in all primary myotubes (Fig. 2, j and 1, arrows) and some (not shown) but not all secondary myotubes (Fig. 2,  j and l, double arrowheads) . These results indicate that the first appearance of the ryanodine receptor in a particular secondary myotube precedes that of TS28. As expected on the basis of the results presented above (Fig. 2, b, d , f, and h), specific labeling for the ryanodine receptor in primary myotubes was present in discrete foci in the outer zone of the cytosol (Fig. 2, i and k) , while specific labeling for TS28 was mostly confined to discrete foei and rod-like structures at the cell periphery (Fig. 2, j and l) .
Confocal Imaging of oo-DHPR versus TS2&
To corn- pare in more detail the distribution of the c~1-DHPR (Fig.  2 , a and c) and TS28 (Fig. 2, b and d) at the early stages of formation of T-tubules (19-24 day of gestation), transverse sections double labeled for both proteins were examined by confocal microscopy which provides a Z-axis resolution of ',~0.8/~m (2) . Fig. 4 shows confocal images of thin optical sections from the central region of a 6-8-~m transverse cryosection of 24-d-old fetal skeletal muscle double labeled for the ott-DHPR (Fig. 4 , a and c) and for TS28 (Fig. 4, b  and d) . Generally, the images obtained in confocal microscopy were similar to those obtained by conventional immunofluorescence microscopy. Thus, it was observed that positive labeling for both the o,-DHPR (Fig. 4 , a and c) and for TS28 (Fig. 4, b and d) was distributed in discrete foci of all primary (Fig. 4, a-d , arrows) and secondary myotubes (Fig. 4, a and b ; single arrowhead). Other secondary myotubes were also labeled for the al-DHPR (Fig. 4 a, double  arrowhead) , but not for TS28 (Fig. 4 b, double arrowhead) . It is noteworthy, however, that a much higher proportion of the foci positively labeled for TS28 was confined to the cell periphery when transverse sections were imaged by confocal microscopy (Fig. 4, b and d) than when imaged by conventional epifluorescence microscopy ( Fig. 2, b, d , j, and l). This is probably to some extent due to the fact that imaging of slightly oblique 6-8-/zm transverse sections of small myotubes by conventional microscopy could make it appear as if some of the peripherally located foci were present in the outer regions of the cytosol. To determine more precisely the spatial distribution of the fluorescent foci positively labeled for ot~-DHPR (Fig. 4 c) and TS28 (Fig. 4 d) in 24-d fetal primary myotubes, tracings of the foci labeled for ot~-DHPR (Fig. 4 e) and TS28 (Fig.  4 f ) were superimposed (Fig. 4j) . Examination of the superimposed tracings (Fig. 4j) revealed three classes of foci, namely (a) foci uniquely labeled for ot1-DHPR (Fig. 4, g and j, open circles); (b) foci uniquely labeled for TS28 (Fig.  4, h and j, open triangles) ; and (c) foci labeled for both ot~-DHPR and TS28 (Fig. 4, i and j, crosses) . Analysis of superimposed tracings of the distribution of fluorescent foci in primary myotubes (n = 15) present in transverse sections of 24-d fetal muscle double labeled for the ot~-DHPR and for TS28 by confocal microscopy showed that 47 + 15 % of the foci were labeled for both the cq-DHPR and TS28, while 21 + 10% and 31 + 12% of the foci were uniquely labeled for TS28 and the o~-DHPR, respectively. Furthermore, qualitative examination of the spatial distribution of the three classes of foci showed that many of the foci uniquely labeled for the cq-DHPR were distributed in the outer zone of the cytosol (Fig. 4j, open circles) , while the foci either uniquely labeled for TS28 (Fig. 4j, open triangles) or labeled for both the at-DHPR and TS28 (Fig. 4 j, crosses) were generally confined to the cell periphery. The considerable variability in the number of foci in the three subclasses is most likely due to the fact that individual primary myotubes in 24-d fetal skeletal muscle are at somewhat different stages of development. However, a more extensive analysis will be required to determine if this is the case.
Newborn 1-2 d aI-DHPR versus TS2g
Examination of transverse sections double labeled for the otl-DHPR (Fig. 5, a and c) and for TS28 (Fig. 5, b and d) showed that all myofibers were positively labeled for both proteins. The otrDHPR was mostly confined to discrete foci present throughout the cytosol (Fig.  5, a and c) . Occasionally, some foci appeared to be connetted with faint fluorescent strands (Fig. 5, a arid c) . In contrast, TS28 was distributed in a chickenwire-like network present throughout the cytosol (Fig. 5, b and d) . While the ot~-DHPR might codistribute with TS28 in parts of the TS28 positively labeled network, it appears that ot~-DHPR is not uniformly distributed in this network.
¢e1-DHPR versus Ryanodine Receptor. Examination of transverse sections double labeled for the cel-DHPR (Fig. 5 , e and g) and for the ryanodine receptor (Fig. 5, f and h) showed that the labeling for the ryanodine receptor (Fig. 5 , f and h) and the ¢x~-DHPR was confined to discrete foci present throughout the cytosol. Furthermore, the distribution of most of the foci positively labeled for the ryanodine receptor (e.g., Fig. 5 h, arrowheads) corresponded very closely to that of the foci positively labeled for the ce~-DHPR (Fig. 5 g, arrowheads) . These results suggest that the ryanodine receptor and the c~t-DHPR also colocalize at this stage of development.
Ryanodine Receptor versus TS2g Examination of transverse sections at this stage of development double labeled for the ryanodine receptor (Fig. 5, i and k) and for TS28 (Fig.  5 , j and l) confirmed the results described above. Thus, as shown in Fig. 5 b, TS28 was distributed in a chickenwire-like network present throughout the cytosol (Fig. 5, j and l) . In contrast, the ryanodine receptor was mostly confined to discrete foci throughout the cytosol of all myofibers (Fig. 5, i  and k) .
Examination of longitudinal sections labeled for either the c~-DHPR (Fig. 6, a and b) , or for the ryanodine receptor (Fig. 6, f a n d g) , showed that the distribution of labeling for the ot~-DPHR and the ryanodine receptor was confined to discrete foci present throughout the cytosol. Occasionally, these foci appeared to be aligned in rows oriented more or less parallel to the longitudinal axis of the myofiber (Fig. 6 b; ~1-DHPR; and Fig. 6 g; ryanodine receptor ). In contrast, labeling for TS28 appeared as previously reported (45) to be distributed in an anastomosing network (Fig. 6, c-e) . The longitudinally oriented component of the anastomosing network is more prominent than the transversely oriented component at this stage of development (Fig. 6, d and e).
Newborn 10 d and Adult
Examination of longitudinal cryosections from 10-d (Fig. 7, Figure 7 . Localization of the ¢Xl-DHPR, the ryanodine receptor, and TS28 in longitudinal cryoseetions of fixed 10-d and adult rabbit skeletal muscle by conventional immunofluoreseence microscopy. Longitudinal eryoseetions of paraformaldehyde (2%) fixed 10-d-old (a, b, and c) and adult rabbit graeilis muscle (d-j) were labeled with affinity-purified antibodies to the ~t-DHPR (a, d, and h), with mAb IXEI12 to TS28 (b and e), with affinity-purified antibodies to the ryanodine receptor (c,f, and i), with affinity-purified antibodies to the c~I-DHPR preadsorped with purified DHPR (g), and with affinity-purified antibodies to the ryanodine receptor preadsorped with purified ryanodine receptor (j). Specific labeling of 10-d-old (a-c) and adult skeletal muscle sections (d-f, h and i) for the ¢x1-DHPR (a, d, and h), TS28 (b and e) and ryanodine receptor (c,f, and i) appears as transversely oriented strands at the junction between the A-and 1-bands as determined by phase-contrast microscopy (not shown). The specific fluorescence labeling for the c~rDHPR seen in d and for the ryanodine receptor seen infis greatly reduced after the preadsorption of these antibodies with purified DHPR (g) and ryanodine receptor (j), respectively. Arrows in h and i point to the position of A-I junctions in these fibers. Bars, 5 #m.
a-c) and adult gracilis muscle (Fig. 7, d-j) immunolabeled for the otrDHPR (Fig. 7, a, d , and h), TS28 (Fig. 7, b and e), and the ryanodine receptor (Fig. 7, c, f, and i) , showed that at both stages of development the distribution of the specific labeling for all three antibodies was indistinguishable and generally confined to transversely oriented strands positioned at the A-I junction as determined by imaging the same field by phase-contrast microscopy (results not shown). The specific fluorescence labeling for the ctt-DHPR (Fig. 7 h, arrows) and for the ryanodine receptor (Fig. 7 i, arrows) sometimes appeared as a transversely oriented row of small bright foci at the A-I junctions in adult skeletal muscle fibers. When the antibodies to the ct~-DHPR and the ryanodine receptor were preadsorbed with highly purified DHPR and the ryanodine receptor, respectively, the specific labeling for the ctrDI-IPR (Fig. 7 d) and for the ryanodine receptor (Fig. 7 f ) was greatly reduced (Fig. 7 , g and j, respectively).
Discussion
To assess at the cellular level whether the T-tubular proteins ott-DHPR and TS28 are incorporated simultaneously or sequentially into forming T-tubules we have used double immunofluorescenee labeling to compare the temporal appearance and subeellular distribution of TS28 to those of oL~-DHPR during the de novo biogenesis of T-tubules and triads in skeletal muscle developing in situ. On the basis of our previous immunofluorescence studies ( 45) we assume that the temporal appearance and subeellular distribution of TS28 represent those of forming T-tubules.
We conclude that in a particular developing myotube the arDHPR appears before the onset of formation ofT-tubules. This conclusion is supported by the results showing that positive labeling for TS28 was not detectable in some of the secondary myotubes in 19-24-d fetal muscle positively labeled for a1-DHPR and is in agreement with results of previous studies on the ontogenesis of the DHPR in developing skeletal muscle (32, 36, 42) showing that a large increase in the number of nitrendipine binding sites (32, 36) and in the amount of mRNA of the al-DHPR (42) are concurrent with fusion of myoblasts into myotubes.
We also conclude that the subceUular distribution of a~-DHPR and TS28 are generally distinct during the early stages of T-tubule formation. Thus, specific labeling for otl-DHPR is distributed at the cell periphery and the outer zone of the cytosol of all myotubes while TS28 as previously shown (45) is confined to discrete foci at the cell periphery when it first appears. Subsequently, TS28 was in contrast to otrDHPR also present in rod-like structures projecting from the cell periphery towards the interior regions of the cytosol. Since otI-DHPR is a membrane protein, these results are consistent with the idea that at early stages of myotube development the otl-DHPR is first synthesized and incorporated into membrane-bound vesicles ( Fig. 8 ; ,4/) that accumulate in the cytosol before the onset of T-tubule formation. This interpretation is also consistent with results presented by Romey et al. (32) F/gum & One plausible scheme for the biogenesis of T-tubules and triads in developing skeletal muscle. First, ~m-DHPR (A/) and ryanodine receptors (B1) are assumed to be synthesized on membrane-bound polyribosomes, incorporated into unique transfer vesicles, and distributed (.42 and 172, respectively). Next, TS28-containing vesicles (el) fuse first with the sarcolemma to form a caveolae (C2). Sequential fusions of TS28-eontaining vesicles to the caveolae result in the formation of a tubular invagination into the myotube (C3-C5). As this occurs, ryanodine receptor-containing vesicles are incorporated into forming SR (B3), followed by complex formation between ryanodine receptors in SR and the arDHPR-containing transfer vesicles (AB4) in the outer zone 0f the cytosol. In turn, the a~-DHPR-containing vesicle of this complex fuses with the TS28-containing forming T-tubules (ABC6), thus, incorporating the am-DHPR-containing vesicles into a discrete region of the forming T-tubules (ABCT) and forming a junctional complex between the T-tubule and the SR.
ing vesicles remain in the outer zone of the cytosol. This interpretation implies that otrDHPRs are not incorporated into forming T-tubules until after the biogenesis of TS28-containing T-tubules has begun.
This interpretation was further supported by analysis of tracings of confocal images of 24-d fetal muscle double labeled for TS28 and o~I-DHPR showing that '~50% (47 + 15%) of the foci in primary myotubes were labeled for both the c~I-DHPR and TS28. Of the remaining loci, '~30% (31 + 12%) were uniquely labeled for the o~-DHPR, and '~20% (21 + 10%) uniquely labeled for TS28. These results support the idea that only 60% of the al-DHPR-labeled foci are incorporated into T-tubules at this stage of development. The finding that most of the foci labeled for both TS28 and the at-DHPR are confined to the cell periphery and most of the foci uniquely labeled for the at-DHPR are in the outer zone of the cytosol is consistent with the idea that the ~q-DHPR at the cell periphery are incorporated into TS28 containing forming T-tubules (45) previously shown to be oriented parallel or obliquely to the long axis of the myotube (19, 34) at the cell periphery, and that the foci uniquely labeled for the o~1-DHPR represent ot|-DHPR-containing membrane vesicles in the outer zone of the cytosol where TS28-containing T-tubules are not yet present. The finding that most of the foci uniquely labeled for TS28 are confined to the cell periphery supports our previous proposal (45) that these loci may represent TS28-containing caveolae, or transverse and oblique sections of TS28-containing tubular structures at the cell periphery lacking the otI-DHPR.
In myotubes from 1-to 2-d-old rabbit skeletal muscle, TS28, as previously shown (45) , was distributed in a chickenwire-like network in transverse sections and as an anastomosing network in longitudinal sections, suggesting that TS28 is uniformly distributed in both transverse and longitudinally oriented T-tubules. In contrast, most of the ot~-DHPR is distributed in discrete foci throughout the cytosol at this stage of development, indicating that ot1-DHPRs are incorporated into discrete regions of both longitudinally and transversely oriented T-tubules possibly corresponding to the region of the junctional complex between T-tubules and the forming junctional SR. This conclusion is consistent with the results of ultrastructural studies, showing that the junctional SR does not form a complete terminal cisternae along the T-tubules at this stage of development (34) .
Assuming that the ryanodine receptor is a specific marker of the junctional region of the junctional SR (18), the temporal appearance of triads and T-tubules was assessed by comparing the subcellular distribution of the ryanodine receptor to that of TS28 and the ~t-DHPR in developing rabbit skeletal muscle. Generally, the results presented show that the temporal appearance and subcellular distribution of the ryanodine receptor are very similar to those of the o~I-DHPR but distinct from those of TS28. Thus, in primary and secondary myotubes from 19-24-d fet~ rabbit skeletal muscle the ryanodine receptor is distributed in foci present in the outer zone of the cytosol supporting the possibility that the ryanodine receptor, like the ot1-DHPR, is a component of membrane-bound structures in this region of the cytosol (Fig. 8, B/) . Since TS28 positive foci are generally absent from the outer zone of the cytosol of 19-24-d fetal myotubes, ryanodine receptor positive foci cannot be components of triads and are more likely components of membrane-bound vesicles either separate from or components of the forming SR. Since double labeling for the ryanodine receptor and the cxt-DHPR of 24-d fetal myotubes also showed that >80% of the foci positively labeled for the ryanodine receptor were also positively labeled for the otrDHPR, these results are consistent with the idea that most of the aa-DHPR incorporated into the TS28-containing T-tubules forming at the cell periphery exist in a complex with ryanodine receptors pres-ent either in discrete membrane vesicles (not shown) or in forming SR. Furthermore, these are also consistent with the idea that ¢x~-DHPR-positive but TS28-negative vesicles in the outer zone of the myotubes also form a complex with ryanodine receptors incorporated into either discrete vesicles (not shown) or into forming SR.
The results of double labeling the 1-2-d-old myotubes for the ryanodine receptor and the ¢xt-DHPR suggested that these two proteins colocalize in foci present in the cytosol. Comparison of these results with the results of double labeling for TS28 and the o~t-DHPR suggest that the ot~-DHPR incorporated into discrete regions of TS28-contalning T-tubules also form a complex with ryanodine receptors incorporated into either discrete vesicles or into forming SR, thus, forming diad structures between T-tubules and either the junctional face of junctional SR or its precursor.
The sequence of events leading to the incorporation of TS28, the ot~-DHPR, and the ryanodine receptor into T-tubules and triads is presently unknown. However, on the basis of our previous studies of the assembly of TS28 into forming T-tubules (45), the results presented here, and current ideas about intracellular membrane trafficking, we propose the following plausible scheme for the correlation between the assembly of (a) TS28 and the ot~-DHPR into T-tubules; and (b) TS28, the at-DHPR, and the ryanodine receptor into a junctional complex between T-tubules and junctional SR (Fig. 8) . First, otrDHPR ( Fig. 8 ; A/) and ryanodine receptors ( Fig. 8; B1 ) are synthesized on membrane-bound polyribosomes, incorporated into distinct vesicles, and distributed throughout the cytoplasm (Fig. 8, A2 and B2, respectively). Next, TS28-containing vesicles fuse with the sarcolemma (Fig. 8, C1 ) thus forming caveolae (Fig. 8, C2 ). Sequential fusions of TS28-contalning vesicles with forming T-tubules (Fig. 8, C4 ) result in the biogenesis of T-tubules (Fig. 8, C5) . As the biogenesis of T-tubules occurs, ryanodine receptor-containing vesicles (Fig. 8, B2 ) are either (a) incorporated into forming SR (Fig. 8, B3 ) followed by formarion of a complex between ryanodine receptors in the SR and a o~rDHPR-containing vesicle (Fig. 8, AB4) ; or (b) form a complex with ott-DHPR-containing vesicles in the interior region of the cytosol (not shown); in turn the a,-DHPR-contalning vesicle of this complex fuses with the TS28 containing forming T-tubules (Fig. 8, ABC6 ), thus incorporating the ot~-DHPR-contalning vesicle of this complex into a discrete region of the forming T-tubules (Fig. 8,  ABCT) . Since the o~t-DHPR is complexed with the ryanodine receptor containing membrane system, incorporation of the o~t-DHPR into T-tubules also results in the formation of a junctional complex between T-tubules and the SR. It appears from the data presented that the ot~-DHPR does not become uniformly distributed along the forming T-tubules in rabbit skeletal muscle until 2 d after birth. However, the results presented do not permit us to conclude whether the ot~-DHPR becomes uniformly distributed throughout the T-tubules as development proceeds or remain confined within the junctional region of the T-tubules. Furthermore, these results do not permit us to conclude whether TS28 in the T-tubules becomes a component of the ot~-DHPR containing junctional region between T-tubules and junctional SR (diads and triads).
To assess the validity of the scheme proposed for the assembly of o~-DHPR, TS28, and the ryanodine receptor into T-tubules and junctional complexes between T-tubules and junctional SR, it will be important to identify the subcellular organelles in developing muscle labeled with antibodies to these proteins by immunoelectron microscopy. These studies should also be helpful in delineating the intracellular pathway taken by the organdies transporting the at-DHPR, TS28, and the ryanodine receptor from the site of synthesis to the site of incorporation into their respective target membranes. This approach should furthermore determine whether the proposed interactions between the proposed "carrier" organelles indeed occur.
The scheme proposed for the assembly of T-tubules and triads implies that o~l-DHPR-containing vesicles play a pivotal role in the assembly of junctional complexes between forming T-tubules and ryanodine receptor containing junctional SR. In this regard, it is interesting that recent studies on dysgenic (mdg/mdg) muscle, an autosomal recessive mutation in mice characterized by the absence of excitation-contraction coupling (11) and a greatly decreased number of triads (30) , have shown that the otrDHPR, but not the ryanodine receptor, is absent from the microsomal fraction of dysgenic muscle (22) . Thus, developing dysgenic muscle should be an excellent model for testing at the cellular level the effect of lack of ~rDHPR on the sequence of events leading to the biogenesis of T-tubules and triads including the effect on intraceUular membrane pathways taking TS28 and the ryanodine receptor from the site of synthesis to their target organeUes.
